Drugs and Devices

FDA clears glucose monitoring system for use in critically ill patients.

On September 24, the U.S. Food and Drug Administration (FDA) cleared a new indication for the Nova StatStrip Glucose Hospital Meter System, extending its use to critically ill patients who have been hospitalized. Read more.


Related Articles:

Leave a Reply

You have to agree to the comment policy.

 

Shares